Cargando…
Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis
BACKGROUND: To evaluate the efficacy and safety of rituximab-based combination therapy for Waldenström macroglobulinemia (WM), we conducted this meta-analysis by pooling the rates of overall response, major response, complete response, and grade ≥3 hematological adverse events. METHODS AND MATERIALS...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469478/ https://www.ncbi.nlm.nih.gov/pubmed/31043792 http://dx.doi.org/10.2147/OTT.S191179 |